Cancer is claiming thousands of Ugandan lives every year. Yet as medical science develops new ways to fight the disease, a troubling question confronts our government: how long must Ugandans wait before promising medical breakthroughs become accessible to them? According to figures cited from the World Health Organisation’s International Agency for Research on Cancer, Uganda recorded an estimated 29,966 new cancer cases and 18,205 cancer-related deaths in 2024. Behind these figures are families losing loved ones, children losing parents and households confronting the emotional and financial consequences of serious illness. The emergence of histotripsy, a technology that destroys selected tumours using focused ultrasound waves without surgical incisions, offers an opportunity to rethink Uganda’s approach to cancer treatment. Authorized in the United States in October 2023 for the destruction of liver tumours, histotripsy achieved technical success in 42 of 44 patients in the HOPE4LIVER trials. That is encouraging, although technical success does not mean a cure. Researchers still need to establish its long-term survival effects. Uganda should neither dismiss such innovation because it is expensive nor embrace it blindly because it is new. The Uganda Cancer Institute should lead a deliberate national effort to assess emerging cancer technologies, encourage clinical research and establish partnerships with international research institutions. Its role should extend beyond providing treatment to helping determine which scientific advances could make the greatest difference to Ugandan patients. Government must support that ambition with sustained investment in research, specialist training, diagnostic equipment and cancer treatment infrastructure. Acquiring sophisticated machines without trained personnel, reliable maintenance arrangements or affordable access would merely replace one healthcare problem with another. Equally, investment in emerging technology must not come at the expense of cancer prevention, early detection, chemotherapy, radiotherapy and surgery. These remain essential. Innovation should strengthen existing services, not undermine them. There is also a question of fairness. If new treatments eventually become available, will they serve ordinary Ugandans or remain accessible only to those who can afford expensive private care? That question should guide decisions about public funding, regulation and partnerships with technology developers. Uganda cannot purchase every medical breakthrough. But it can establish a credible process to evaluate promising innovations, support locally relevant research, and introduce proven treatments responsibly. The greater failure would be to watch medical science advance while doing little to prepare our health system to benefit from it. Cancer patients deserve more than expressions of sympathy. They deserve a government willing to invest in knowledge, technology and the institutions capable of turning scientific progress into longer, healthier lives.The post Uganda must invest in the future of cancer treatment appeared first on The Observer Media Ltd.